个人中心 - 老虎社区

Elizsg

IP属地：未知

帖子 · 10帖子 · 10
关注 · 0关注 · 0
粉丝 · 0粉丝 · 0

- ElizsgElizsg
  ·2021-11-16
  Considering to buy..
  非常抱歉，此主贴已删除
  664 1
  2
  分享
  举报
- ElizsgElizsg
  ·2021-11-16
  $AMD(AMD)$😊😊
  790 评论
  4
  分享
  举报
- ElizsgElizsg
  ·2021-11-16
  $Tiger Brokers(TIGR)$waiting and waiting
  742 1
  3
  分享
  举报
- ElizsgElizsg
  ·2021-11-11
  Ok
  Apple launches subscription service aimed at small-business users
  (Reuters) - Apple Inc on Wednesday launched a new subscription service aimed at helping small-busine
  Apple launches subscription service aimed at small-business users
  783 评论
  2
  分享
  举报
- ElizsgElizsg
  ·2021-11-11
  Nice
  非常抱歉，此主贴已删除
  632 评论
  4
  分享
  举报
- ElizsgElizsg
  ·2021-11-05
  $Tiger Brokers(TIGR)$go go go Tiger...
  804 评论
  点赞
  分享
  举报
- ElizsgElizsg
  ·2021-11-02
  🤔🤔🤔
  非常抱歉，此主贴已删除
  890 1
  点赞
  分享
  举报
- ElizsgElizsg
  ·2021-11-02
  Way to go!!!
  Novavax COVID-19 vaccine gets first authorization; expects more within weeks, CEO says
  (Reuters) -Novavax Inc expects regulators in India, the Philippines and elsewhere to make a decision
  Novavax COVID-19 vaccine gets first authorization; expects more within weeks, CEO says
  834 1
  1
  分享
  举报
- ElizsgElizsg
  ·2021-11-02
  $Novavax(NVAX)$go go go
  913 评论
  点赞
  分享
  举报
- ElizsgElizsg
  ·2021-11-02
  $AMD(AMD)$Should I get more ? 🤔
  750 评论
  点赞
  分享
  举报
暂无关注

热议股票

{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"4098023813313270","uuid":"4098023813313270","gmtCreate":1634954372466,"gmtModify":1635817255066,"name":"Elizsg","pinyin":"elizsg","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/a986801b7e893d2dcc3bf7574fd66181","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":4,"headSize":18,"tweetSize":10,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.03.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":871255284,"gmtCreate":1637075898747,"gmtModify":1637075898877,"author":{"id":"4098023813313270","authorId":"4098023813313270","name":"Elizsg","avatar":"https://static.tigerbbs.com/a986801b7e893d2dcc3bf7574fd66181","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098023813313270","authorIdStr":"4098023813313270"},"themes":[],"htmlText":"Considering to buy..","listText":"Considering to buy..","text":"Considering to buy..","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/871255284","repostId":"1167542836","repostType":4,"isVote":1,"tweetType":1,"viewCount":664,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":871209175,"gmtCreate":1637071007542,"gmtModify":1637071007719,"author":{"id":"4098023813313270","authorId":"4098023813313270","name":"Elizsg","avatar":"https://static.tigerbbs.com/a986801b7e893d2dcc3bf7574fd66181","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098023813313270","authorIdStr":"4098023813313270"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AMD\">$AMD(AMD)$</a>😊😊","listText":"<a href=\"https://laohu8.com/S/AMD\">$AMD(AMD)$</a>😊😊","text":"$AMD(AMD)$😊😊","images":[{"img":"https://static.tigerbbs.com/ada91389ab8bdc1676e92dc2a0dbeafd","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/871209175","isVote":1,"tweetType":1,"viewCount":790,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":871121294,"gmtCreate":1637038818412,"gmtModify":1637038818412,"author":{"id":"4098023813313270","authorId":"4098023813313270","name":"Elizsg","avatar":"https://static.tigerbbs.com/a986801b7e893d2dcc3bf7574fd66181","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098023813313270","authorIdStr":"4098023813313270"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>waiting and waiting&nbsp;","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>waiting and waiting&nbsp;","text":"$Tiger Brokers(TIGR)$waiting and waiting","images":[{"img":"https://static.tigerbbs.com/1906d06e636b33f50a50c8ccbec0624a","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/871121294","isVote":1,"tweetType":1,"viewCount":742,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":870051726,"gmtCreate":1636560552553,"gmtModify":1636560552553,"author":{"id":"4098023813313270","authorId":"4098023813313270","name":"Elizsg","avatar":"https://static.tigerbbs.com/a986801b7e893d2dcc3bf7574fd66181","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098023813313270","authorIdStr":"4098023813313270"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/870051726","repostId":"1146312365","repostType":4,"repost":{"id":"1146312365","kind":"news","pubTimestamp":1636557036,"share":"https://www.laohu8.com/m/news/1146312365?lang=&edition=full","pubTime":"2021-11-10 23:10","market":"us","language":"en","title":"Apple launches subscription service aimed at small-business users","url":"https://stock-news.laohu8.com/highlight/detail?id=1146312365","media":"Reuters","summary":"(Reuters) - Apple Inc on Wednesday launched a new subscription service aimed at helping small-busine","content":"<p>(Reuters) - Apple Inc on Wednesday launched a new subscription service aimed at helping small-business owners manage the Apple devices used by their employees.</p>\n<p>Business Essentials, as Apple is calling the service, is similar to management software that companies such as Microsoft Corp or VMware Inc sell to large business for setting up and keeping secure their fleets of phones, laptops and tablets. But Apple's version is simplified for businesses with between 50 and 500 employees that have either a small IT department or none at all.</p>\n<p>The service will cost between $2.99 and $12.99 per month per user depending on how many devices a business wants to manage for each employee and how much cloud storage the business wants.</p>\n<p>For an additional monthly cost, Apple will also offer a service to repair or replace broken hardware at a business within four hours, though the company said it has not yet determined pricing for that service.</p>\n<p>\"Time is of the essence - for small businesses, it's one of their most valuable resources,\" Susan Prescott, Apple’s vice president of enterprise and education marketing, told Reuters in an interview. \"As they start to grow, there are more demands on their time. And that can be in lieu of running the business doing the things they need to do.\"</p>\n<p>Maribel Lopez, founder and principal analyst at Lopez Research, said the pairing of management software with a repair service subscription is unique in the industry.</p>\n<p>\"People are going to think that part doesn't matter, but I think they're underestimating the power of being able to get really good service,\" she said.</p>\n<p>Apple said it will start testing Business Essentials in the United States on Wednesday, and it will be free until the service is finalized next year. Apple plans to expand it to other locations in the future, executives said.</p>","source":"lsy1612507957220","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple launches subscription service aimed at small-business users</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple launches subscription service aimed at small-business users\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-10 23:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/apple-launches-subscription-aimed-small-150536799.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Reuters) - Apple Inc on Wednesday launched a new subscription service aimed at helping small-business owners manage the Apple devices used by their employees.\nBusiness Essentials, as Apple is calling...</p>\n\n<a href=\"https://finance.yahoo.com/news/apple-launches-subscription-aimed-small-150536799.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://finance.yahoo.com/news/apple-launches-subscription-aimed-small-150536799.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1146312365","content_text":"(Reuters) - Apple Inc on Wednesday launched a new subscription service aimed at helping small-business owners manage the Apple devices used by their employees.\nBusiness Essentials, as Apple is calling the service, is similar to management software that companies such as Microsoft Corp or VMware Inc sell to large business for setting up and keeping secure their fleets of phones, laptops and tablets. But Apple's version is simplified for businesses with between 50 and 500 employees that have either a small IT department or none at all.\nThe service will cost between $2.99 and $12.99 per month per user depending on how many devices a business wants to manage for each employee and how much cloud storage the business wants.\nFor an additional monthly cost, Apple will also offer a service to repair or replace broken hardware at a business within four hours, though the company said it has not yet determined pricing for that service.\n\"Time is of the essence - for small businesses, it's one of their most valuable resources,\" Susan Prescott, Apple’s vice president of enterprise and education marketing, told Reuters in an interview. \"As they start to grow, there are more demands on their time. And that can be in lieu of running the business doing the things they need to do.\"\nMaribel Lopez, founder and principal analyst at Lopez Research, said the pairing of management software with a repair service subscription is unique in the industry.\n\"People are going to think that part doesn't matter, but I think they're underestimating the power of being able to get really good service,\" she said.\nApple said it will start testing Business Essentials in the United States on Wednesday, and it will be free until the service is finalized next year. Apple plans to expand it to other locations in the future, executives said.","news_type":1},"isVote":1,"tweetType":1,"viewCount":783,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":870051566,"gmtCreate":1636560518490,"gmtModify":1636560518490,"author":{"id":"4098023813313270","authorId":"4098023813313270","name":"Elizsg","avatar":"https://static.tigerbbs.com/a986801b7e893d2dcc3bf7574fd66181","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098023813313270","authorIdStr":"4098023813313270"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/870051566","repostId":"2182326730","repostType":4,"isVote":1,"tweetType":1,"viewCount":632,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":846975420,"gmtCreate":1636043751995,"gmtModify":1636043752073,"author":{"id":"4098023813313270","authorId":"4098023813313270","name":"Elizsg","avatar":"https://static.tigerbbs.com/a986801b7e893d2dcc3bf7574fd66181","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098023813313270","authorIdStr":"4098023813313270"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>go go go Tiger...&nbsp;","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>go go go Tiger...&nbsp;","text":"$Tiger Brokers(TIGR)$go go go Tiger...","images":[{"img":"https://static.tigerbbs.com/3bd7b10bab2997adaeafd2daabd4dfea","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/846975420","isVote":1,"tweetType":1,"viewCount":804,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":843153015,"gmtCreate":1635814348262,"gmtModify":1635814348262,"author":{"id":"4098023813313270","authorId":"4098023813313270","name":"Elizsg","avatar":"https://static.tigerbbs.com/a986801b7e893d2dcc3bf7574fd66181","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098023813313270","authorIdStr":"4098023813313270"},"themes":[],"htmlText":"🤔🤔🤔","listText":"🤔🤔🤔","text":"🤔🤔🤔","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/843153015","repostId":"2180209042","repostType":4,"isVote":1,"tweetType":1,"viewCount":890,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":843127725,"gmtCreate":1635814264167,"gmtModify":1635814264167,"author":{"id":"4098023813313270","authorId":"4098023813313270","name":"Elizsg","avatar":"https://static.tigerbbs.com/a986801b7e893d2dcc3bf7574fd66181","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098023813313270","authorIdStr":"4098023813313270"},"themes":[],"htmlText":"Way to go!!!&nbsp;","listText":"Way to go!!!&nbsp;","text":"Way to go!!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/843127725","repostId":"1118798908","repostType":4,"repost":{"id":"1118798908","kind":"news","pubTimestamp":1635810877,"share":"https://www.laohu8.com/m/news/1118798908?lang=&edition=full","pubTime":"2021-11-02 07:54","market":"us","language":"en","title":"Novavax COVID-19 vaccine gets first authorization; expects more within weeks, CEO says","url":"https://stock-news.laohu8.com/highlight/detail?id=1118798908","media":"Reuters","summary":"(Reuters) -Novavax Inc expects regulators in India, the Philippines and elsewhere to make a decision","content":"<p>(Reuters) -Novavax Inc expects regulators in India, the Philippines and elsewhere to make a decision on its COVID-19 vaccine within “weeks,” its chief executive told Reuters, after the shot on Monday received its first emergency use authorization (EUA) from Indonesia.</p>\n<p>FILE PHOTO: A woman holds a small bottle labeled with a \"Coronavirus COVID-19 Vaccine\" sticker and a medical syringe in front of displayed Novavax logo in this illustration taken, October 30, 2020. REUTERS/Dado Ruvic</p>\n<p>Novavax shares were up about 13% after the company also said it had filed an application for emergency use of the vaccine to Canada and the European Medicines Agency.</p>\n<p>For Indonesia, the shot will be manufactured by the world’s largest vaccine manufacturer, Serum Institute in India (SII), and sold under the Indian company’s brand name, Covovax. Novavax said initial shipments into Indonesia are expected to begin imminently.</p>\n<p>The World Health Organization (WHO) is also reviewing Novavax’s regulatory filing and the U.S. drugmaker expects that review to be resolved in the coming weeks, Chief Executive Stanley Erck told Reuters in a phone interview on Monday.</p>\n<p>A green light from the WHO would set the stage for Novavax to begin shipping doses to the COVAX program that supplies shots to low-income countries. Novavax and SII have together committed to provide more than 1.1 billion doses to COVAX, which is co-led by the WHO.</p>\n<p>“I think we’ll get some doses to COVAX this year,” Erck said. “But I think (Novavax is) going to really start being able to ship large quantity to COVAX in the first quarter” of 2022.</p>\n<p>Erck said Novavax has resolved all of its manufacturing challenges and does not expect regulators to have any further concerns about its production processes.</p>\n<p>He said Novavax is “in dialogue with the U.S. FDA and ... we expect a full submission within the next several weeks.”</p>\n<p>Novavax had delayed filing for U.S. approval, and Politico reported last month that the company faced production and quality problems.</p>\n<p>SII is authorized to make the Novavax vaccine and the U.S. company said it will apply for regulatory authorization for other facilities, such as its plant in the Czech republic, in the coming weeks.</p>\n<p>Indonesia is slated to receive 20 million doses of the protein-based vaccine this year, according to the government.</p>\n<p>Penny Lukito, chief of the National Agency for Drug and Food Control of Indonesia, did not immediately respond to a Reuters request for comment.</p>\n<p>Novavax has so far applied for EUA in various countries, including the UK, Australia, India and the Philippines.</p>\n<p>“It will be weeks, not months, for them to review” Novavax’s regulatory submissions and potentially clear the shot for use, Erck said.</p>\n<p>The company, along with Japanese partner Takeda Pharmaceutical Co, said on Friday it was preparing to seek regulatory approval for a rollout in Japan early next year.</p>\n<p>The Novavax shot was shown to be more than 90% effective, including against a variety of concerning variants of the coronavirus in a large, late-stage U.S.-based trial.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax COVID-19 vaccine gets first authorization; expects more within weeks, CEO says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax COVID-19 vaccine gets first authorization; expects more within weeks, CEO says\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-02 07:54 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.reuters.com/article/health-coronavirus-novavax/update-3-novavax-covid-19-vaccine-gets-first-authorization-expects-more-within-weeks-ceo-says-idUSL4N2RS2MV><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Reuters) -Novavax Inc expects regulators in India, the Philippines and elsewhere to make a decision on its COVID-19 vaccine within “weeks,” its chief executive told Reuters, after the shot on Monday ...</p>\n\n<a href=\"https://www.reuters.com/article/health-coronavirus-novavax/update-3-novavax-covid-19-vaccine-gets-first-authorization-expects-more-within-weeks-ceo-says-idUSL4N2RS2MV\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"source_url":"https://www.reuters.com/article/health-coronavirus-novavax/update-3-novavax-covid-19-vaccine-gets-first-authorization-expects-more-within-weeks-ceo-says-idUSL4N2RS2MV","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1118798908","content_text":"(Reuters) -Novavax Inc expects regulators in India, the Philippines and elsewhere to make a decision on its COVID-19 vaccine within “weeks,” its chief executive told Reuters, after the shot on Monday received its first emergency use authorization (EUA) from Indonesia.\nFILE PHOTO: A woman holds a small bottle labeled with a \"Coronavirus COVID-19 Vaccine\" sticker and a medical syringe in front of displayed Novavax logo in this illustration taken, October 30, 2020. REUTERS/Dado Ruvic\nNovavax shares were up about 13% after the company also said it had filed an application for emergency use of the vaccine to Canada and the European Medicines Agency.\nFor Indonesia, the shot will be manufactured by the world’s largest vaccine manufacturer, Serum Institute in India (SII), and sold under the Indian company’s brand name, Covovax. Novavax said initial shipments into Indonesia are expected to begin imminently.\nThe World Health Organization (WHO) is also reviewing Novavax’s regulatory filing and the U.S. drugmaker expects that review to be resolved in the coming weeks, Chief Executive Stanley Erck told Reuters in a phone interview on Monday.\nA green light from the WHO would set the stage for Novavax to begin shipping doses to the COVAX program that supplies shots to low-income countries. Novavax and SII have together committed to provide more than 1.1 billion doses to COVAX, which is co-led by the WHO.\n“I think we’ll get some doses to COVAX this year,” Erck said. “But I think (Novavax is) going to really start being able to ship large quantity to COVAX in the first quarter” of 2022.\nErck said Novavax has resolved all of its manufacturing challenges and does not expect regulators to have any further concerns about its production processes.\nHe said Novavax is “in dialogue with the U.S. FDA and ... we expect a full submission within the next several weeks.”\nNovavax had delayed filing for U.S. approval, and Politico reported last month that the company faced production and quality problems.\nSII is authorized to make the Novavax vaccine and the U.S. company said it will apply for regulatory authorization for other facilities, such as its plant in the Czech republic, in the coming weeks.\nIndonesia is slated to receive 20 million doses of the protein-based vaccine this year, according to the government.\nPenny Lukito, chief of the National Agency for Drug and Food Control of Indonesia, did not immediately respond to a Reuters request for comment.\nNovavax has so far applied for EUA in various countries, including the UK, Australia, India and the Philippines.\n“It will be weeks, not months, for them to review” Novavax’s regulatory submissions and potentially clear the shot for use, Erck said.\nThe company, along with Japanese partner Takeda Pharmaceutical Co, said on Friday it was preparing to seek regulatory approval for a rollout in Japan early next year.\nThe Novavax shot was shown to be more than 90% effective, including against a variety of concerning variants of the coronavirus in a large, late-stage U.S.-based trial.","news_type":1},"isVote":1,"tweetType":1,"viewCount":834,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":843120781,"gmtCreate":1635813817715,"gmtModify":1635813817715,"author":{"id":"4098023813313270","authorId":"4098023813313270","name":"Elizsg","avatar":"https://static.tigerbbs.com/a986801b7e893d2dcc3bf7574fd66181","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098023813313270","authorIdStr":"4098023813313270"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/NVAX\">$Novavax(NVAX)$</a>go go go","listText":"<a href=\"https://laohu8.com/S/NVAX\">$Novavax(NVAX)$</a>go go go","text":"$Novavax(NVAX)$go go go","images":[{"img":"https://static.tigerbbs.com/e6d2588d85dd0979cebf43f0999a9bb6","width":"1080","height":"3162"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/843120781","isVote":1,"tweetType":1,"viewCount":913,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":843187953,"gmtCreate":1635813269704,"gmtModify":1635813269704,"author":{"id":"4098023813313270","authorId":"4098023813313270","name":"Elizsg","avatar":"https://static.tigerbbs.com/a986801b7e893d2dcc3bf7574fd66181","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098023813313270","authorIdStr":"4098023813313270"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AMD\">$AMD(AMD)$</a>Should I get more ? 🤔&nbsp;","listText":"<a href=\"https://laohu8.com/S/AMD\">$AMD(AMD)$</a>Should I get more ? 🤔&nbsp;","text":"$AMD(AMD)$Should I get more ? 🤔","images":[{"img":"https://static.tigerbbs.com/7940ccb8297f0d04a14ed23b34c428f9","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/843187953","isVote":1,"tweetType":1,"viewCount":750,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0}],"defaultTab":"following","isTTM":false}